Research progress of Sigma receptor antagoinsts in the drug abuse-mediated neurotoxicity

ZHANG Yuan; SUN Jiarui; LIU Yuqiu; CHAO Jie; YAO Honghong

doi:10.11665/j.issn.1000-5048.20140301

Journal of China Pharmaceutical University > 2014 > 45(3): 253-258. > DOI: 10.11665/j.issn.1000-5048.20140301

ZHANG Yuan, SUN Jiarui, LIU Yuqiu, CHAO Jie, YAO Honghong. Research progress of Sigma receptor antagoinsts in the drug abuse-mediated neurotoxicity[J]. Journal of China Pharmaceutical University, 2014, 45(3): 253-258. DOI: 10.11665/j.issn.1000-5048.20140301

Citation:

PDF (1469 KB)

Research progress of Sigma receptor antagoinsts in the drug abuse-mediated neurotoxicity

More Information

Graphical Abstract

Abstract

Abstract

Drug abuse represents a serious health issue worldwide resulting personal suffering, as well as social and economic burden. Drug abuse is considered the third killer in some western societies since it affects more and more people, compared with cerebral-cardiovascular disease or malignant cancer. China faces emerging epidemics of drug abuse as evidenced that drug abusers are on the rise in recent years. Despite the recognized impact of drug abuse on the brain reward system, mechanisms underlying the ability of drug abuse to initiate a cascade of neuroinflammatory response, which finally result in widespread neurotoxicity within the complex network of cell-to-cell interactions, have not yet been fully identified. Understanding the detailed mechanisms underlying neuropathological progression induced by drug abuse is thus the next logical step that is of paramount importance. The control and eradication of neurological complications associated with drug abuse continues to be an important goal toward improving the well-being of drug abusers. This review summarizes the potential role of Sigma receptor antagoinsts in drug abuse-mediated neuroinflammation and neurotoxicity, both of which comprise the hallmark features of drug abusers. These findings will set a stage for providing a new generation of novel therapeutic agents for drug abuse involving neuroinflammation and neurotoxicity.
- Sigma receptor,
- antagoinst,
- drug abuse,
- neurotoxicity,
- cocaine,
- methamphetamine,
- morphine

FullText(HTML)

References (45)

References

[1]	Schmitt KC,Reith ME.Regulation of the dopamine transporter:aspects relevant to psychostimulant drugs of abuse[J].Ann N Y Acad Sci,2010,1 187:316-340.
[2]	Iversen L.Neurotransmitter transporters and their impact on the development of psychopharmacology[J].Br J Pharmacol,2006,147(Suppl 1):S82-88.
[3]	Yao H,Yang Y,Kim KJ,et al.Molecular mechanisms involving sigma receptor-mediated induction of MCP-1:implication for increased monocyte transmigration[J].Blood,2010,115(23):4 951-4 962.
[4]	Little KY,Ramssen E,Welchko R,et al.Decreased brain dopamine cell numbers in human cocaine users[J].Psychiatry Res,2009,168(3):173-180.
[5]	Buttner A.Review:the neuropathology of drug abuse[J].Neuropathol Appl Neurobiol,2011,37(2):118-134.
[6]	Martin WR,Eades CG,Thompson JA,et al.The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog[J].J Pharmacol Exp Ther,1976,197(3):517-532.
[7]	Su TP,London ED,Jaffe JH.Steroid binding at sigma receptors suggests a link between endocrine,nervous,and immune systems[J].Science,1988,240(4 849):219-221.
[8]	Kourrich S,Su TP,Fujimoto M,et al.The sigma-1 receptor:roles in neuronal plasticity and disease[J].Trends Neurosci,2012,35(12):762-771.
[9]	Nuwayhid SJ,Werling LL.Sigma1 receptor agonist-mediated regulation of N-methyl-D-aspartate-stimulated[3H]dopamine release is dependent upon protein kinase C[J].J Pharmacol Exp Ther,2003,304(1):364-369.
[10]	Matsumoto RR,Liu Y,Lerner M,et al.Sigma receptors:potential medications development target for anti-cocaine agents[J].Eur J Pharmacol,2003,469(1/2/3):1-12.
[11]	Hayashi T,Su TP.Regulating ankyrin dynamics:Roles of sigma-1 receptors[J].Proc Natl Acad Sci U S A,2001,98(2):491-496.
[12]	Su TP,Shukla K,Gund T.Steroid binding at sigma receptors:CNS and immunological implications[J].Ciba Found Symp,1990,153:107-113;discussion 113-106.
[13]	Hashimoto K,Ishiwata K.Sigma receptor ligands:possible application as therapeutic drugs and as radiopharmaceuticals[J].Curr Pharm Des,2006,12(30):3 857-3 876.
[14]	Huang YS,Lu HL,Zhang LJ,et al.Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy[J].Med Res Rev,2014,34(3):532-566.
[15]	Cobos EJ,Entrena JM,Nieto FR,et al.Pharmacology and therapeutic potential of sigma(1)receptor ligands[J].Curr Neuropharmacol,2008,6(4):344-366.
[16]	Narayanan S,Mesangeau C,Poupaert JH,et al.Sigma receptors and cocaine abuse[J].Curr Top Med Chem,2011,11(9):1 128-1 150.
[17]	Rodvelt KR,Miller DK.Could sigma receptor ligands be a treatment for methamphetamine addiction[J]?Curr Drug Abuse Rev,2010,3(3):156-162.
[18]	Matsumoto RR. Targeting sigma receptors: novel medication development for drug abuse and addiction[J].Expert Rev Clin Pharmacol,2009,2(4):351-358.
[19]	Xu YT,Robson MJ,Szeszel-Fedorowicz W,et al.CM156,a sigma receptor ligand,reverses cocaine-induced place conditioning and transcriptional responses in the brain[J].Pharmacol Biochem Behav,2012,101(1):174-180.
[20]	Robson MJ,Turner RC,Naser ZJ,et al.SN79,a sigma receptor ligand,blocks methamphetamine-induced microglial activation and cytokine upregulation[J].Exp Neurol,2013,247:134-142.
[21]	Kaushal N,Matsumoto RR.Role of sigma receptors in methamphetamine-induced neurotoxicity[J].Curr Neuropharmacol,2011,9(1):54-57.
[22]	Sharkey J,Glen KA,Wolfe S,et al.Cocaine binding at sigma receptors[J].Eur J Pharmacol,1988,149(1/2):171-174.
[23]	Gan X,Zhang L,Berger O,et al.Cocaine enhances brain endothelial adhesion molecules and leukocyte migration[J].Clin Immunol,1999,91(1):68-76.
[24]	Yao H,Duan M,Hu G,et al.Platelet-derived growth factor B chain is a novel target gene of cocaine-mediated Notch1 signaling:implications for HIV-associated neurological disorders[J].J Neurosci,2011,31(35):12 449-12 454.
[25]	Yao H,Kim K,Duan M,et al.Cocaine hijacks sigma1 receptor to initiate induction of activated leukocyte cell adhesion molecule:implication for increased monocyte adhesion and migration in the CNS[J].J Neurosci,2011,31(16):5 942-5 955.
[26]	Hall AA,Herrera Y,Ajmo CT Jr,et al.Sigma receptors suppress multiple aspects of microglial activation[J].Glia,2009,57(7):744-754.
[27]	Cuevas J,Rodriguez A,Behensky A,et al.Afobazole modulates microglial function via activation of both sigma-1 and sigma-2 receptors[J].J Pharmacol Exp Ther,2011,339(1):161-172.
[28]	Gekker G, Hu S, Sheng WS, et al. Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1[J].Int Immunopharmacol,2006,6(6):1 029-1 033.
[29]	Roth MD,Tashkin DP,Choi R,et al.Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes[J].J Infect Dis,2002,185(5):701-705.
[30]	Roth MD, Whittaker KM, Choi R, et al. Cocaine and sigma-1 receptors modulate HIV infection,chemokine receptors,and the HPA axis in the huPBL-SCID model[J].J Leukoc Biol,2005,78(6):1 198-1 203.
[31]	Ben-Ami O, Kinor N, Perelman A, et al. Dopamine-1 receptor agonist,but not cocaine,modulates sigma(1)gene expression in SVG cells[J].J Mol Neurosci,2006,29(2):169-176.
[32]	Krasnova IN,Cadet JL.Methamphetamine toxicity and messengers of death[J].Brain Res Rev,2009,60(2):379-407.
[33]	Nguyen EC,McCracken KA,Liu Y,et al.Involvement of sigma(sigma)receptors in the acute actions of methamphetamine:receptor binding and behavioral studies[J].Neuropharmacology,2005,49(5):638-645.
[34]	Kaushal N,Seminerio MJ,Shaikh J,et al.CM156,a high affinity sigma ligand,attenuates the stimulant and neurotoxic effects of methamphetamine in mice[J].Neuropharmacology,2011,61(5/6):992-1 000.
[35]	Matsumoto RR,Shaikh J,Wilson LL,et al.Attenuation of methamphetamine-induced effects through the antagonism of sigma(sigma)receptors:evidence from in vivo and in vitro studies[J].Eur Neuropsychopharmacol,2008,18(12):871-881.
[36]	Smith KJ, Butler TR, Prendergast MA. Inhibition of sigma-1 receptor reduces N-methyl-D-aspartate induced neuronal injury in methamphetamine-exposed and -naive hippocampi[J].Neurosci Lett,2010,481(3):144-148.
[37]	Seminerio MJ,Hansen R,Kaushal N,et al.The evaluation of AZ66,an optimized sigma receptor antagonist,against methamphetamine-induced dopaminergic neurotoxicity and memory impairment in mice[J].Int J Neuropsychopharmacol,2013,16(5):1 033-1 044.
[38]	Robson MJ,Seminerio MJ,McCurdy CR,et al.sigma Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation[J].Pharmacol Rep,2013,65(2):343-349.
[39]	Northrop NA,Yamamoto BK.Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier[J].J Neuroimmune Pharmacol,2012,7(4):951-968.
[40]	Bowyer JF,Thomas M,Schmued LC,et al.Brain region-specific neurodegenerative profiles showing the relative importance of amphetamine dose,hyperthermia,seizures,and the blood-brain barrier[J].Ann N Y Acad Sci,2008,1 139:127-139.
[41]	Martins T,Baptista S,Goncalves J,et al.Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus:role of tight junction proteins and matrix metalloproteinase-9[J].Brain Res,2011,1 411:28-40.
[42]	Bowyer JF,Robinson B,Ali S,et al.Neurotoxic-related changes in tyrosine hydroxylase,microglia,myelin,and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure[J].Synapse,2008,62(3):193-204.
[43]	Bowyer JF,Ali S.High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus[J].Synapse,2006,60(7):521-532.
[44]	Chen SL,Hsu KY,Huang EY,et al.Low doses of dextromethorphan attenuate morphine-induced rewarding via the sigma-1 receptor at ventral tegmental area in rats[J].Drug Alcohol Depend,2011,117(2/3):164-169.
[45]	Sabino V,Cottone P,Zhao Y,et al.The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking[J].Neuropsychopharmacology,2009,34(6):1 482-1 493.

[1]	WU Lingxi, DU Yixuan, GAO Xiangdong. Inhibitory effect of IL-27 on the overactivation of microglia[J]. Journal of China Pharmaceutical University, 2024, 55(6): 801-808. DOI: 10.11665/j.issn.1000-5048.2024022702
[2]	CUI Tao, WU Weidang, CI Xiaoyan, LI Wei, GUO Chuanmin, XU Jing, YI Xiulin, LIU Changxiao. Evaluation of tolerance and pharmacodynamics of nano-micelle irinotecan formulation[J]. Journal of China Pharmaceutical University, 2019, 50(2): 175-179. DOI: 10.11665/j.issn.1000-5048.20190207
[3]	YUE Juanjuan, CUI Hanyue, WANG Hui, YE Bin, CHEN Dingding. Protective effects of losartan potassium on 5/6 nephrectomy-induced chronic heart failure in rats[J]. Journal of China Pharmaceutical University, 2016, 47(6): 734-739. DOI: 10.11665/j.issn.1000-5048.20160617
[4]	JIANG Yuqiu, TANG Qiaofei, ZHANG Shuang, YAN Zhiyong. Combined effects of gallic acid and ciprofloxacin on the murine chronic rhinosinusitis model in mice[J]. Journal of China Pharmaceutical University, 2015, 46(5): 600-604. DOI: 10.11665/j.issn.1000-5048.20150514
[5]	CHEN Lu, LI Jiajie, PAN Cailong, ZHOU Danli, LIU Wentao, ZHANG Guangqin. Tetramethylpyrazine attenuates morphine tolerance through suppressing spinal microglia activation in mice[J]. Journal of China Pharmaceutical University, 2015, 46(2): 230-234. DOI: 10.11665/j.issn.1000-5048.20150216
[6]	WANG Yu, ZHAO Li, MIAO Hanchi, LI Zhiyu, GUO Qinglong. Apoptosis induction of oroxylin A in human chronic myelogenous leukemia cell line K562[J]. Journal of China Pharmaceutical University, 2014, 45(2): 232-236. DOI: 10.11665/j.issn.1000-5048.20140218
[7]	DENG Danni, TIAN Hong, YAO Wenbing. Advances in therapeutic B-cell vaccines against chronic diseases[J]. Journal of China Pharmaceutical University, 2013, 44(5): 470-475. DOI: 10.11665/j.issn.1000-5048.20130517
[8]	FENG Lan-ying, HUANG Wen-ye. Expression and regulation of Bim protein in chronic myelogenous leukemia[J]. Journal of China Pharmaceutical University, 2009, 40(6): 571-575.
[9]	Effect of Amygdalin on Chronic Gastritis and Chronic Atrophic Gastritis[J]. Journal of China Pharmaceutical University, 2002, (1): 47-49.
[10]	Study on the Tolerance of the Rabbit Body Temperature Response to Bacterial Endotoxin[J]. Journal of China Pharmaceutical University, 1999, (3): 64-66.

Cited By

Get Citation

PDF

XML

Article views (1413) PDF downloads (2591)

Turn off MathJax

Article Contents

Abstract

References

Research progress of Sigma receptor antagoinsts in the drug abuse-mediated neurotoxicity

Abstract

References

Related Articles

Catalog

Research progress of Sigma receptor antagoinsts in the drug abuse-mediated neurotoxicity

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content